ProPhase Labs, Inc.
PRPH
$0.3288
-$0.0063-1.88%
NASDAQ
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -12.86% | 706.36% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -12.86% | 706.36% | |||
| Cost of Revenue | -43.31% | 294.21% | |||
| Gross Profit | 39.54% | 128.70% | |||
| SG&A Expenses | 13.00% | -74.43% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 0.92% | -67.34% | |||
| Operating Income | -6.31% | 76.86% | |||
| Income Before Tax | 21.06% | 73.11% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 4.40% | 85.36% | |||
| Earnings from Discontinued Operations | -- | 458.97% | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -212.76% | 111.54% | |||
| EBIT | -6.31% | 76.86% | |||
| EBITDA | -16.69% | 85.63% | |||
| EPS Basic | -195.65% | 107.08% | |||
| Normalized Basic EPS | 48.34% | 83.19% | |||
| EPS Diluted | -197.69% | 107.08% | |||
| Normalized Diluted EPS | 48.34% | 83.19% | |||
| Average Basic Shares Outstanding | 17.90% | 72.18% | |||
| Average Diluted Shares Outstanding | 17.90% | 72.18% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||